PDZ-mediated signaling through syndecan-4

PDZ 通过 syndecan-4 介导的信号传导

基本信息

  • 批准号:
    6612585
  • 负责人:
  • 金额:
    $ 27.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-01 至 2006-07-31
  • 项目状态:
    已结题

项目摘要

The interaction between the carboxy terminus of transmembrane receptors with the conserved PDZ binding module of adaptor proteins has emerged as a major mechanism of organizing signal-transduction protein complexes. The syndecan family of transmembrane proteoglycans belongs to this large group of PDZ- binding cell surface receptors. Until recently, the generally held concept of proteoglycan functions was centered on their heparan sulfate chains as the active component involved in binding of growth factors and of extracellular matrix proteins. This view is undergoing a revision, however, as a consequence of newly emerging findings, which suggest that the highly conserved cytoplasmic tails of the syndecan family of transmembrane proteoglycans also participate in the transduction of outside-in signals. While all the syndecans possess a PDZ-binding carboxy- terminus, the widely expressed syndecan-4 contains a unique phosphatidylinositol 4,5-bisphosphate binding domain in its cytoplasmic tail, and facilitates the activation of protein kinase C alpha. Recent findings from our laboratory indicate that the interaction between the cytoplasmic tail of syndecan-4 and PDZ domain-containing protein(s) is essential for the cellular response to basic fibroblast growth factor, as demonstrated by the impairment of migration, of proliferation, and of vascular network formation by endothelial cells upon the disruption of this interaction. The objective of this proposal is to elucidate the nature of the signaling mechanism through the PDZ-syndecan-4 interaction, employing the recently identified syndecan-4 PDZ partner synectin as a prototype. This interaction is part of a novel FGF signaling pathway, and forms a new paradigm for the regulation of signal transduction. We will focus on (1) characterizing the binding mechanism between syndecan-4 and synectin, (2) identifying additional synectin binding partners other than syndecan-4, in order to determine further downstream members of the syndecan-4-mediated signaling pathway, and (3) characterize the functions of synectin in general, and the endothelial cell-specific ones in particular, by a synectin gene knockout mouse model.
跨膜受体的羧基端与接头蛋白的保守的PDZ结合模块之间的相互作用已成为组织信号转导蛋白复合物的主要机制。跨膜蛋白聚糖家族属于这一大群结合PDZ的细胞表面受体。直到最近,人们普遍认为蛋白聚糖的功能集中在它们的硫酸肝素链上,它是参与生长因子和细胞外基质蛋白结合的活性成分。然而,由于新发现表明,syndecan跨膜蛋白聚糖家族的高度保守的细胞质尾部也参与了外向内信号的转导,这一观点正在经历修订。虽然所有的syndecan都有一个结合pdz的羧基端,但广泛表达的syndecan-4在其细胞质尾部含有一个独特的磷脂酰肌醇4,5-二磷酸结合域,并促进蛋白激酶C α的激活。我们实验室最近的研究结果表明,syndecan-4的细胞质尾部与含有PDZ结构域的蛋白之间的相互作用对于细胞对碱性成纤维细胞生长因子的反应至关重要,这种相互作用被破坏时内皮细胞的迁移、增殖和血管网络形成受到损害。本提案的目的是通过PDZ-syndecan-4相互作用阐明信号传导机制的本质,采用最近发现的syndecan-4 PDZ伴侣连接蛋白作为原型。这种相互作用是一种新的FGF信号通路的一部分,并形成了信号转导调节的新范式。我们将重点关注(1)表征syndecan-4与syndecan-4之间的结合机制,(2)识别除syndecan-4以外的其他syndecan-4结合伙伴,以确定syndecan-4介导的信号通路的进一步下游成员,以及(3)通过连接蛋白基因敲除小鼠模型表征连接蛋白的一般功能,特别是内皮细胞特异性功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arie Horowitz其他文献

Arie Horowitz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arie Horowitz', 18)}}的其他基金

Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
  • 批准号:
    8694252
  • 财政年份:
    2014
  • 资助金额:
    $ 27.65万
  • 项目类别:
Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
  • 批准号:
    8827843
  • 财政年份:
    2014
  • 资助金额:
    $ 27.65万
  • 项目类别:
Regulation of endothelial cell junctions by VEGF and angiopoietin
VEGF 和血管生成素对内皮细胞连接的调节
  • 批准号:
    9225233
  • 财政年份:
    2014
  • 资助金额:
    $ 27.65万
  • 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
  • 批准号:
    6545320
  • 财政年份:
    2002
  • 资助金额:
    $ 27.65万
  • 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
  • 批准号:
    6787673
  • 财政年份:
    2002
  • 资助金额:
    $ 27.65万
  • 项目类别:
PDZ-mediated signaling through syndecan-4
PDZ 通过 syndecan-4 介导的信号传导
  • 批准号:
    6930468
  • 财政年份:
    2002
  • 资助金额:
    $ 27.65万
  • 项目类别:

相似国自然基金

PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
  • 批准号:
    82372275
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
  • 批准号:
    82300356
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
Tom1L1在胞内体蛋白分选机制中功能的研究
  • 批准号:
    31171289
  • 批准年份:
    2011
  • 资助金额:
    56.0 万元
  • 项目类别:
    面上项目
溶酶体依赖性TRAF2降解的机制
  • 批准号:
    30971501
  • 批准年份:
    2009
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目

相似海外基金

Elucidation of metabolic control mechanism by FGF21-mediated central nervous system signaling in neonatal period
阐明新生儿期 FGF21 介导的中枢神经系统信号传导的代谢控制机制
  • 批准号:
    23K10836
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction
SEMA6D 介导的乳腺癌差异、转移和肿瘤免疫相互作用
  • 批准号:
    10634959
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
空气污染介导的肥胖加剧中的肾素-血管紧张素系统。
  • 批准号:
    10654124
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Gene regulatory networks in early lung epithelial cell fate decisions
早期肺上皮细胞命运决定中的基因调控网络
  • 批准号:
    10587615
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
调节PD-1/PD-L1检查点促进肉瘤患者HER2 CAR T细胞的抗肿瘤活性
  • 批准号:
    10562836
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Structural understanding of 7SK-snRNP mediated transcriptional regulation
7SK-snRNP 介导的转录调控的结构理解
  • 批准号:
    10583647
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Mitochondria-targeted antioxidant supplementation for improving age-related vascular dysfunction in older adults: the role of circulating factors
线粒体靶向抗氧化剂补充剂可改善老年人与年龄相关的血管功能障碍:循环因子的作用
  • 批准号:
    10606926
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Injury Response Mediated Pathogenesis in Renal Ciliopathies
损伤反应介导的肾纤毛病发病机制
  • 批准号:
    10571152
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
Metabolic mechanisms of cognitive decline in aging and AD mediated by inflammatory PGE2 signaling
炎症 PGE2 信号介导的衰老和 AD 认知能力下降的代谢机制
  • 批准号:
    10590390
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation
ELAVL1通过细胞融合和隧道膜纳米管形成介导的细胞间基因转移在胶质母细胞瘤异质性中的作用
  • 批准号:
    10658226
  • 财政年份:
    2023
  • 资助金额:
    $ 27.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了